Iron Dosing Pilot Study Using Model Predictive Control
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Renal Impairment / Chronic Kidney Disease, Renal Impairment / Chronic Kidney Disease, Anemia, Anemia |
| Therapuetic Areas: | Hematology, Nephrology / Urology |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 8/18/2018 |
| Start Date: | October 2018 |
| End Date: | March 2019 |
| Contact: | Michael Brier, PhD |
| Email: | mbrier@louisville.edu |
| Phone: | 502-852-5757 |
This is a pilot study to test the utility of an integrated approach in the management of the
anemia of chronic kidney disease through the administration of both an erythropoietic
stimulating agent and iron. Subjects will be studied for 6 months during which all iron
dosing will be recommended using a computer based tool using model predictive control.
Comparisons will be made to the 6 months prior to enrollment in to the study.
anemia of chronic kidney disease through the administration of both an erythropoietic
stimulating agent and iron. Subjects will be studied for 6 months during which all iron
dosing will be recommended using a computer based tool using model predictive control.
Comparisons will be made to the 6 months prior to enrollment in to the study.
Inclusion Criteria:
- chronic kidney disease
- anemia
- receiving intravenous iron
Exclusion Criteria:
We found this trial at
1
site
University of Louisville The University of Louisville is a state supported research university located in...
Click here to add this to my saved trials
